–
Cellectar Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.1
FY22:
−28.8
FY23:
−39.0
FY24:
−51.8
FY25:
−23.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.0
FY22:
−32.3
FY23:
−35.0
FY24:
−65.3
FY25:
−23.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.1
FY22:
−31.9
FY23:
−42.8
FY24:
−44.5
FY25:
−21.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.1
FY22:
−31.8
FY23:
−42.8
FY24:
−44.6
FY25:
−21.8
All amounts in millions USD